MENU
+Compare
STRO
Stock ticker: NASDAQ
AS OF
Jan 14 closing price
Price
$12.66
Change
+$2.03 (+19.10%)
Capitalization
107.86M

STRO Sutro Biopharma Inc. Forecast, Technical & Fundamental Analysis

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company... Show more

STRO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STRO with price predictions
Jan 14, 2026

Momentum Indicator for STRO turns positive, indicating new upward trend

STRO saw its Momentum Indicator move above the 0 level on January 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for STRO just turned positive on January 14, 2026. Looking at past instances where STRO's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

STRO moved above its 50-day moving average on December 19, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for STRO crossed bullishly above the 50-day moving average on December 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STRO advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 105 cases where STRO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for STRO moved out of overbought territory on January 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where STRO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STRO broke above its upper Bollinger Band on January 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.785) is normal, around the industry mean (27.929). P/E Ratio (0.000) is within average values for comparable stocks, (51.397). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.899). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (1.004) is also within normal values, averaging (329.547).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
STRO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STRO is expected to report earnings to fall 35.10% to -43 cents per share on March 12

Sutro Biopharma Inc. STRO Stock Earnings Reports
Q4'25
Est.
$-0.43
Q3'25
Missed
by $0.27
Q2'25
Beat
by $0.27
Q1'25
Missed
by $0.06
Q4'24
Est.
$-0.83
The last earnings report on November 06 showed earnings per share of -67 cents, missing the estimate of -40 cents. With 244.19K shares outstanding, the current market capitalization sits at 107.86M.
A.I. Advisor
published General Information

General Information

a developer of new products in protein vaccines and therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
111 Oyster Point Boulevard
Phone
+1 650 881-6500
Employees
324
Web
https://www.sutrobio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKHC27.801.50
+5.70%
Horizon Kinetics Holding Corporation
CMBNF91.31N/A
N/A
CEMBRA MONEY BK AG
CHEAF0.63N/A
N/A
China Eastern Airlines Corp. Ltd.
BIOE0.05N/A
N/A
Bio Essence Corp.
VEXTF0.19N/A
-1.71%
Vext Science Inc.

STRO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with BEAM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+19.10%
BEAM - STRO
39%
Loosely correlated
+2.49%
SMMT - STRO
37%
Loosely correlated
+5.00%
IDYA - STRO
37%
Loosely correlated
+5.53%
PRQR - STRO
35%
Loosely correlated
N/A
AXON - STRO
35%
Loosely correlated
-1.92%
More